Compare US Global Jets ETF (JETS) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
US Global Jets ETF vs Johnson & Johnson — how do they compare? US Global Jets ETF trades at $31.73, while Johnson & Johnson trades at $260.96 (market cap $626.09B). The key difference: Johnson & Johnson pays a 2.06% dividend while US Global Jets ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, US Global Jets ETF nearer its low. Which is the better fit depends on your goals.
| JETS | JNJ | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $33.53 | $267.24 |
52-Week Low | $23.64 | $172.78 |
Market Cap | — | $626.09B |
Volume | — | 6,156,228 |
Enterprise Value | — | $654.37B |
Dividend Yield | — | 2.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JETS trades at $31.63, up 0.6% on the day, with a bullish technical signal from moving averages but neutral oscillators. Recent news highlights airline earnings beats and government rebates for plane retrofits, though fuel cost volatility remains a headwind. The ETF focuses on U.S. airline operators, offering exposure to travel demand but facing cyclical risks.
Outlook is mixed: lower oil prices support profitability, but geopolitical tensions and fuel swings pose risks. JETS provides diversified airline exposure but underperforms defense-focused peers on expense ratios and drawdowns. Investor sentiment is cautious amid earnings revisions and sector comparisons.
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About US Global Jets ETF
JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
